EUROFINS SCIENTIFIC (ESF0.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:ESF0 - FR0014000MR3 - Common Stock
57.48 EUR
+1.68 (+3.01%)
Taking everything into account, ESF0 scores 5 out of 10 in our fundamental rating. ESF0 was compared to 20 industry peers in the Life Sciences Tools & Services industry. ESF0 has only an average score on both its financial health and profitability. ESF0 is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
ESF0 had positive earnings in the past year.
In the past year ESF0 had a positive cash flow from operations.
Each year in the past 5 years ESF0 has been profitable.
In the past 5 years ESF0 always reported a positive cash flow from operatings.
1.2 Ratios
With a Return On Assets value of 3.54%, ESF0 perfoms like the industry average, outperforming 45.00% of the companies in the same industry.
ESF0 has a Return On Equity (8.09%) which is comparable to the rest of the industry.
ESF0 has a better Return On Invested Capital (9.79%) than 75.00% of its industry peers.
ESF0 had an Average Return On Invested Capital over the past 3 years of 8.70%. This is in line with the industry average of 9.25%.
The last Return On Invested Capital (9.79%) for ESF0 is above the 3 year average (8.70%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.54% | ||
| ROE | 8.09% | ||
| ROIC | 9.79% |
ROA(3y)3.79%
ROA(5y)5.05%
ROE(3y)7.94%
ROE(5y)10.72%
ROIC(3y)8.7%
ROIC(5y)10.54%
1.3 Margins
ESF0's Profit Margin of 5.44% is on the low side compared to the rest of the industry. ESF0 is outperformed by 65.00% of its industry peers.
In the last couple of years the Profit Margin of ESF0 has grown nicely.
The Operating Margin of ESF0 (15.59%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of ESF0 has grown nicely.
The Gross Margin of ESF0 (23.29%) is worse than 85.00% of its industry peers.
ESF0's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.59% | ||
| PM (TTM) | 5.44% | ||
| GM | 23.29% |
OM growth 3Y-11.93%
OM growth 5Y3.56%
PM growth 3Y-23.05%
PM growth 5Y9.75%
GM growth 3Y-7.6%
GM growth 5Y1.83%
2. Health
2.1 Basic Checks
ESF0 has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for ESF0 has been reduced compared to 1 year ago.
Compared to 5 years ago, ESF0 has more shares outstanding
ESF0 has a better debt/assets ratio than last year.
2.2 Solvency
ESF0 has an Altman-Z score of 2.61. This is not the best score and indicates that ESF0 is in the grey zone with still only limited risk for bankruptcy at the moment.
ESF0's Altman-Z score of 2.61 is in line compared to the rest of the industry. ESF0 outperforms 55.00% of its industry peers.
The Debt to FCF ratio of ESF0 is 5.25, which is a neutral value as it means it would take ESF0, 5.25 years of fcf income to pay off all of its debts.
ESF0 has a Debt to FCF ratio of 5.25. This is in the better half of the industry: ESF0 outperforms 65.00% of its industry peers.
ESF0 has a Debt/Equity ratio of 0.77. This is a neutral value indicating ESF0 is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.77, ESF0 is not doing good in the industry: 65.00% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | 5.25 | ||
| Altman-Z | 2.61 |
ROIC/WACC1.21
WACC8.07%
2.3 Liquidity
ESF0 has a Current Ratio of 1.26. This is a normal value and indicates that ESF0 is financially healthy and should not expect problems in meeting its short term obligations.
ESF0 has a Current ratio (1.26) which is comparable to the rest of the industry.
ESF0 has a Quick Ratio of 1.19. This is a normal value and indicates that ESF0 is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of ESF0 (1.19) is better than 85.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.26 | ||
| Quick Ratio | 1.19 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 16.50% over the past year.
ESF0 shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 18.34% yearly.
ESF0 shows a small growth in Revenue. In the last year, the Revenue has grown by 2.53%.
ESF0 shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.78% yearly.
EPS 1Y (TTM)16.5%
EPS 3Y-21.42%
EPS 5Y18.34%
EPS Q2Q%19.61%
Revenue 1Y (TTM)2.53%
Revenue growth 3Y1.14%
Revenue growth 5Y8.78%
Sales Q2Q%5.64%
3.2 Future
Based on estimates for the next years, ESF0 will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.60% on average per year.
Based on estimates for the next years, ESF0 will show a small growth in Revenue. The Revenue will grow by 7.38% on average per year.
EPS Next Y14.43%
EPS Next 2Y13.37%
EPS Next 3Y13.84%
EPS Next 5Y15.6%
Revenue Next Year5.07%
Revenue Next 2Y5.39%
Revenue Next 3Y5.87%
Revenue Next 5Y7.38%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 15.97, the valuation of ESF0 can be described as correct.
ESF0's Price/Earnings ratio is a bit cheaper when compared to the industry. ESF0 is cheaper than 80.00% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.76, ESF0 is valued a bit cheaper.
With a Price/Forward Earnings ratio of 14.48, ESF0 is valued correctly.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ESF0 indicates a somewhat cheap valuation: ESF0 is cheaper than 80.00% of the companies listed in the same industry.
ESF0 is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.96, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.97 | ||
| Fwd PE | 14.48 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ESF0 indicates a rather cheap valuation: ESF0 is cheaper than 85.00% of the companies listed in the same industry.
90.00% of the companies in the same industry are more expensive than ESF0, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.35 | ||
| EV/EBITDA | 8.14 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
ESF0 has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as ESF0's earnings are expected to grow with 13.84% in the coming years.
PEG (NY)1.11
PEG (5Y)0.87
EPS Next 2Y13.37%
EPS Next 3Y13.84%
5. Dividend
5.1 Amount
ESF0 has a Yearly Dividend Yield of 1.02%.
ESF0's Dividend Yield is rather good when compared to the industry average which is at 0.71. ESF0 pays more dividend than 90.00% of the companies in the same industry.
With a Dividend Yield of 1.02, ESF0 pays less dividend than the S&P500 average, which is at 2.31.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.02% |
5.2 History
On average, the dividend of ESF0 grows each year by 16.51%, which is quite nice.
Dividend Growth(5Y)16.51%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
54.91% of the earnings are spent on dividend by ESF0. This is a bit on the high side, but may be sustainable.
The dividend of ESF0 is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP54.91%
EPS Next 2Y13.37%
EPS Next 3Y13.84%
FRA:ESF0 (12/11/2025, 7:00:00 PM)
57.48
+1.68 (+3.01%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners36.14%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap10.47B
Revenue(TTM)6.89B
Net Income(TTM)374.80M
Analysts69.47
Price Target65.82 (14.51%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.02% |
Yearly Dividend0.52
Dividend Growth(5Y)16.51%
DP54.91%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.85%
PT rev (3m)1.93%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.19%
EPS NY rev (3m)0.94%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)-0.76%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.97 | ||
| Fwd PE | 14.48 | ||
| P/S | 1.52 | ||
| P/FCF | 13.35 | ||
| P/OCF | 7.96 | ||
| P/B | 2.26 | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.14 |
EPS(TTM)3.6
EY6.26%
EPS(NY)3.97
Fwd EY6.91%
FCF(TTM)4.3
FCFY7.49%
OCF(TTM)7.22
OCFY12.56%
SpS37.84
BVpS25.45
TBVpS-3.69
PEG (NY)1.11
PEG (5Y)0.87
Graham Number45.4
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.54% | ||
| ROE | 8.09% | ||
| ROCE | 12.64% | ||
| ROIC | 9.79% | ||
| ROICexc | 10.74% | ||
| ROICexgc | 34.1% | ||
| OM | 15.59% | ||
| PM (TTM) | 5.44% | ||
| GM | 23.29% | ||
| FCFM | 11.37% |
ROA(3y)3.79%
ROA(5y)5.05%
ROE(3y)7.94%
ROE(5y)10.72%
ROIC(3y)8.7%
ROIC(5y)10.54%
ROICexc(3y)9.52%
ROICexc(5y)11.6%
ROICexgc(3y)31.02%
ROICexgc(5y)39.55%
ROCE(3y)11.31%
ROCE(5y)13.7%
ROICexgc growth 3Y-18.17%
ROICexgc growth 5Y3.78%
ROICexc growth 3Y-15.5%
ROICexc growth 5Y6.63%
OM growth 3Y-11.93%
OM growth 5Y3.56%
PM growth 3Y-23.05%
PM growth 5Y9.75%
GM growth 3Y-7.6%
GM growth 5Y1.83%
F-Score7
Asset Turnover0.65
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | 5.25 | ||
| Debt/EBITDA | 2.1 | ||
| Cap/Depr | 84.94% | ||
| Cap/Sales | 7.7% | ||
| Interest Coverage | 9.93 | ||
| Cash Conversion | 77.37% | ||
| Profit Quality | 209.21% | ||
| Current Ratio | 1.26 | ||
| Quick Ratio | 1.19 | ||
| Altman-Z | 2.61 |
F-Score7
WACC8.07%
ROIC/WACC1.21
Cap/Depr(3y)89.21%
Cap/Depr(5y)85.64%
Cap/Sales(3y)8.63%
Cap/Sales(5y)7.99%
Profit Quality(3y)162.79%
Profit Quality(5y)158.88%
High Growth Momentum
Growth
EPS 1Y (TTM)16.5%
EPS 3Y-21.42%
EPS 5Y18.34%
EPS Q2Q%19.61%
EPS Next Y14.43%
EPS Next 2Y13.37%
EPS Next 3Y13.84%
EPS Next 5Y15.6%
Revenue 1Y (TTM)2.53%
Revenue growth 3Y1.14%
Revenue growth 5Y8.78%
Sales Q2Q%5.64%
Revenue Next Year5.07%
Revenue Next 2Y5.39%
Revenue Next 3Y5.87%
Revenue Next 5Y7.38%
EBIT growth 1Y14.03%
EBIT growth 3Y-10.93%
EBIT growth 5Y12.66%
EBIT Next Year83.84%
EBIT Next 3Y29.85%
EBIT Next 5Y22.43%
FCF growth 1Y113.13%
FCF growth 3Y-7.69%
FCF growth 5Y25.62%
OCF growth 1Y31.31%
OCF growth 3Y-4.44%
OCF growth 5Y14.24%
EUROFINS SCIENTIFIC / ESF0.DE FAQ
Can you provide the ChartMill fundamental rating for EUROFINS SCIENTIFIC?
ChartMill assigns a fundamental rating of 6 / 10 to ESF0.DE.
Can you provide the valuation status for EUROFINS SCIENTIFIC?
ChartMill assigns a valuation rating of 7 / 10 to EUROFINS SCIENTIFIC (ESF0.DE). This can be considered as Undervalued.
What is the profitability of ESF0 stock?
EUROFINS SCIENTIFIC (ESF0.DE) has a profitability rating of 6 / 10.
Can you provide the expected EPS growth for ESF0 stock?
The Earnings per Share (EPS) of EUROFINS SCIENTIFIC (ESF0.DE) is expected to grow by 14.43% in the next year.
Can you provide the dividend sustainability for ESF0 stock?
The dividend rating of EUROFINS SCIENTIFIC (ESF0.DE) is 4 / 10 and the dividend payout ratio is 54.91%.